What does a low fetal fraction of 25% mean for non-invasive prenatal testing (NIPT) results?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: May 31, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

A fetal fraction of 25% for non-invasive prenatal testing (NIPT) is considered high and indicates an excellent sample for testing. Typically, a fetal fraction of at least 4% is required for reliable NIPT results, with most tests requiring between 2-4% as the minimum threshold 1. At 25%, the amount of fetal DNA in the maternal blood sample is well above this minimum requirement, which means the test should provide highly accurate results with a reduced chance of test failure or inconclusive findings. This high fetal fraction occurs because there is a substantial amount of placental DNA (which represents the fetal genetic material) circulating in the maternal bloodstream.

  • Factors that can influence fetal fraction include:
    • Gestational age
    • Maternal weight
    • Certain pregnancy complications With a 25% fetal fraction, patients can feel confident in the reliability of their NIPT results, whether those results are positive or negative for the chromosomal conditions being screened. No additional testing would be needed based solely on the fetal fraction percentage, though follow-up diagnostic testing might still be recommended if the NIPT results indicate an increased risk for a chromosomal abnormality, as low fetal fractions and failed results have been associated with fetal aneuploidy 1.

From the Research

Fetal Fraction and Non-Invasive Prenatal Testing (NIPT)

  • Fetal fraction (FF) is a crucial component of NIPT results, representing the proportion of fetal DNA in the maternal bloodstream 2.
  • A low fetal fraction of 25% may indicate a higher risk of false negative results or failed NIPT tests 3.
  • The fetal fraction can be influenced by various biological factors and bioinformatics algorithms used to interpret DNA sequencing results 2.

Implications of Low Fetal Fraction

  • A low fetal fraction may require additional testing or confirmation using invasive techniques, such as amniocentesis or chorionic villus sampling 4, 5.
  • Emerging solutions, such as size selection of shorter cell-free DNA fragments, may help decrease the false negative rate of NIPT and improve test accuracy 3.
  • Clinicians should be aware of the potential limitations of NIPT and the importance of fetal fraction in interpreting test results 2, 6.

NIPT and Fetal Fraction Measurement

  • Different sequencing technologies and bioinformatics algorithms may affect the measurement of fetal fraction, and there is no universal threshold applicable across all platforms 2.
  • The development of new technologies and methods, such as targeted sequencing and assessment of single nucleotide polymorphism differences, may improve the accuracy and reliability of NIPT results 4, 6.
  • Fetal fraction enrichment and improved sequencing techniques may enable the detection of additional chromosomal abnormalities and increase the sensitivity of NIPT 6, 3.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Non-invasive prenatal testing for aneuploidy: current status and future prospects.

Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology, 2013

Research

Chorionic villus sampling and amniocentesis.

Current opinion in obstetrics & gynecology, 2005

Research

Noninvasive prenatal testing: the future is now.

Reviews in obstetrics & gynecology, 2013

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.